186.Full.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
What's the Best First Line Anticonvulsant?
What’s the best first line anticonvulsant? Stephen Hanson, DVM, MS, Dip. ACVIM (Neurology) Recurring seizure activity is a relatively common problem in canine patients. Nowadays, there are several good options for medical treatment, which makes the choice of which drug to use a little more complicated. All anticonvulsant drugs have advantages and disadvantages, so the selection of a first-line drug should be tailored for the individual patient and client. Phenobarbital: This has been the standard first choice drug for decades. The nice thing about Phenobarbital is that it works fairly well, controlling seizures in about 70% of dogs with epilepsy. Also, it is inexpensive and readily available. The biggest down-sides are its induction of hepatic metabolism and the need for frequent upward dose adjustments, as well as its potential to cause hepatotoxicity. The potential for liver disease increases with time, so a 2 year old dog placed on this medication is more likely to develop hepatotoxicity in his life-time than a 10 year old dog. Phenobarbital can also cause sedation and ataxia. While this is usually mild/transient, it can be a real problem in dogs with other pre- existing signs of intracranial disease. Polyuria, polydipsia and polyphagia are other common side effects. These signs vary widely in severity between patients. Pros: cheap, available at any corner pharmacy, works well Cons: higher doses required with time, possible serious liver side-effects Good first-line choice for middle-aged to older dogs without any pre-existing liver issues Poor choice for dogs with liver disease, dogs with other intracranial signs Questionable choice for young epileptic dogs Potassium/sodium bromide: This was the most commonly-used add on anticonvulsant drug for a long time. -
Product Information Sodium Thiocyanate
Product Information Sodium Thiocyanate 98% Product Description: Sodium thiocyanate 98% is an odorless, white solid. Produced from cyanide with sulfur. It is one of the main sources of the thiocyanate ion making it useful as a precursor to a lot of specialty chemicals. Applications: Sodium thiocyanate is used as a concrete hardener accelerator and can be used with other accelerators. It is used as a corrosion inhibitor, in synthetic fibre production, electroplating and pesticide. Chemical Formula: NaSCN CAS No. : 540-72-7 Specifications: Parameters (units) Specifications Sodium thiocyanate (%) ≥ 98 Chloride (%) ≤ 0.06 Sulfate (%) ≤ 0.2 Iron (%) ≤ 0.0005 Heavy metals (%) ≤ 0.001 Insolubles (%) ≤ 0.006 Moisture content (%) ≤ 1.0 pH 6.0 - 8.0 Bisley International LLC 1790 Hughes Landing Boulevard Suite 400 The Woodlands 77380 TX USA Phone number: +1 (281) 506 046 Emergency telephone number: +1 855 237 5573 bisleyinternational.com Copyright 2021 Bisley & Co. Pty Ltd. All rights reserved Packaging: Material is available in 25 kg bags and 950 kg bulk bags. Further packaging options may be available upon enquiry. Storage: Product should be stored in a dry place away from direct sunlight in sealed, original packaging. Safety: For further safety information refer to product SDS available from your Bisley International contact. Disclaimer: This document is for information purposes only. Customers are responsible for testing and confirming the suitability of this product in their application. To the extent permitted by law, no warranty as to merchantability or fitness of purpose, expressed or implied, is made. Global Headquarters Regional offices Sydney, Australia Jakarta, Indonesia Bangkok, Thailand Bisley & Company PT Bisindo Kencana Bisley Asia (Thailand) Co. -
Microemulsion and Oil Soluble Gassing System
Europaisches Patentamt (19) European Patent Office Office europeeneen des brevets £P 0 775 681 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) intci.6: C06B 23/00, C06B 47/14 28.05.1997 Bulletin 1997/22 (21) Application number: 96308223.5 (22) Date of filing: 14.11.1996 (84) Designated Contracting States: (72) Inventor: Chattopadhyay, Arun Kumar DE FR GB SE Quebec J4Z 3E6 (CA) (30) Priority: 24.11.1995 CA 2163682 (74) Representative: Ede, Eric Fitzpatricks, (71) Applicant: ICI Canada Inc. 4 West Regent Street North York Ontario M2N 6H2 (CA) Glasgow G2 1 RS, Scotland (GB) (54) Microemulsion and oil soluble gassing system (57) The present invention relates to a process for microemulsions of the present invention provides more preparing an emulsion explosive which has been sensi- complete mixing of the gas precursor with the constitu- tized by the in-situ gassing of a chemical gassing agent, ents of the emulsion explosives. The process thus pro- wherein the gassing agent is contained in a microemul- vides a more controllable reaction for the in-situ, chem- sion. The invention also relates to the microemulsions ical gassing of emulsions, and for the production of utilized in the practise of this process. The use of the chemically gassed emulsion explosives at lower tem- perature. FIGURE Density (g/cc) i 1.3 1.2 1.1 h 1.0 00 CO 30 Time (mins) lO Is- Is- o a. LU Printed by Jouve, 75001 PARIS (FR) EP 0 775 681 A1 Description Field of the Invention 5 This invention relates to an improved process for preparing an emulsion explosive and incorporation of a dispersed gaseous phase within the emulsion. -
ISOPROPYL THIOCYANATE [Thiocyanic Acid, Isopropyl Ester]
A Publication of Reliable Methods for the Preparation of Organic Compounds Working with Hazardous Chemicals The procedures in Organic Syntheses are intended for use only by persons with proper training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices in the Laboratory" (The National Academies Press, Washington, D.C., 2011; the full text can be accessed free of charge at http://www.nap.edu/catalog.php?record_id=12654). All chemical waste should be disposed of in accordance with local regulations. For general guidelines for the management of chemical waste, see Chapter 8 of Prudent Practices. In some articles in Organic Syntheses, chemical-specific hazards are highlighted in red “Caution Notes” within a procedure. It is important to recognize that the absence of a caution note does not imply that no significant hazards are associated with the chemicals involved in that procedure. Prior to performing a reaction, a thorough risk assessment should be carried out that includes a review of the potential hazards associated with each chemical and experimental operation on the scale that is planned for the procedure. Guidelines for carrying out a risk assessment and for analyzing the hazards associated with chemicals can be found in Chapter 4 of Prudent Practices. The procedures described in Organic Syntheses are provided as published and are conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein. -
1 Abietic Acid R Abrasive Silica for Polishing DR Acenaphthene M (LC
1 abietic acid R abrasive silica for polishing DR acenaphthene M (LC) acenaphthene quinone R acenaphthylene R acetal (see 1,1-diethoxyethane) acetaldehyde M (FC) acetaldehyde-d (CH3CDO) R acetaldehyde dimethyl acetal CH acetaldoxime R acetamide M (LC) acetamidinium chloride R acetamidoacrylic acid 2- NB acetamidobenzaldehyde p- R acetamidobenzenesulfonyl chloride 4- R acetamidodeoxythioglucopyranose triacetate 2- -2- -1- -β-D- 3,4,6- AB acetamidomethylthiazole 2- -4- PB acetanilide M (LC) acetazolamide R acetdimethylamide see dimethylacetamide, N,N- acethydrazide R acetic acid M (solv) acetic anhydride M (FC) acetmethylamide see methylacetamide, N- acetoacetamide R acetoacetanilide R acetoacetic acid, lithium salt R acetobromoglucose -α-D- NB acetohydroxamic acid R acetoin R acetol (hydroxyacetone) R acetonaphthalide (α)R acetone M (solv) acetone ,A.R. M (solv) acetone-d6 RM acetone cyanohydrin R acetonedicarboxylic acid ,dimethyl ester R acetonedicarboxylic acid -1,3- R acetone dimethyl acetal see dimethoxypropane 2,2- acetonitrile M (solv) acetonitrile-d3 RM acetonylacetone see hexanedione 2,5- acetonylbenzylhydroxycoumarin (3-(α- -4- R acetophenone M (LC) acetophenone oxime R acetophenone trimethylsilyl enol ether see phenyltrimethylsilyl... acetoxyacetone (oxopropyl acetate 2-) R acetoxybenzoic acid 4- DS acetoxynaphthoic acid 6- -2- R 2 acetylacetaldehyde dimethylacetal R acetylacetone (pentanedione -2,4-) M (C) acetylbenzonitrile p- R acetylbiphenyl 4- see phenylacetophenone, p- acetyl bromide M (FC) acetylbromothiophene 2- -5- -
United States Patent Office Patented Apr
3,509,255 United States Patent Office Patented Apr. 28, 1970 1. 2 biotics Annual, 1953-1954, pages 191-194, Medical En 3,509,255 cyclopedia, Inc., New York, N.Y. PROCESS FOR THE RECRYSTALLIZATION The recovery of nystatin by isopropanol extraction of OF NYSTATIN Harold Mendelsohn, Nanuet, N.Y., assignor to American the whole broth resulting from the fermentation of the Cyanamid Company, Stamford, Conn., a corporation of nystatin producing Streptomyces noursei is described in Maine U.S. Patent No. 2,786,781 to Vandeputte et al. The par No Drawing. Filed July 2, 1968, Ser. No. 741,912 tially purified product obtained by the Vandeputte et al. Int. Cl. A61k 21/00 process is a therapeutically useful product of about 65 U.S. C. 424-123 10 Claims 70% purity. At best, however it is only partially crystal line and for the most part is substantially non-crystalline or amorphous in character. The purification of nystatin ABSTRACT OF THE DISCLOSURE employing methanolic-calcium chloride is also described This disclosure describes a process for preparing highly in U.S. Patent No. 2,832,719 to Vandeputte and in U.S. purified crystalline nystatin by extracting crude nystatin Patent No. 2,865,807 to Dutcher et al. The product ob with acetone which is saturated with sodium iodide, 15 tained by the Vandeputte and Dutcher et al. processes is Sodium thiocyanate, potassium thiocyanate or ammonium a therapeutically useful highly refined product substan thiocyanate; and precipitating highly purified crystalline tially crystalline in character. nystatin from the extract by displacement of the acetone The processes described above produce crystalline ny with water. -
Experiment 4
Experiment Chemical Equilibrium 4 A reversible reaction is the type of reaction where a certain chemical process is able to proceed in a forward or reverse direction depending on experimental conditions. The chemical equation, which represents this, is written with double arrows as follows: aA + bB ⇄ cC + dD In an equation as above, the chemical symbols (capitol letters) represent not only moles of the substances involved in the process but also moles per liter of the substances. The lower case letters are the stoichiometric coefficients. At equilibrium, the rate of the forward reaction is equal to the rate of the reverse reaction. The equilibrium constant is expressed as the concentrations of the products over the concentrations of the reactants. [C]c[D]d K [A]a[B]b In a reversible system, the species involved (on both sides of the double arrows) will be at a dynamic equilibrium with each other, so that a small disturbance of this balance affecting either side of the equation will involve all the species. The formal way of stating this is called Le Chatlier’s Principle - If stress is placed on a system at equilibrium, the equilibrium will shift in a direction in order to overcome the stress. The stress could be a change of concentration of one or more of the chemical species, change of pressure, change of temperature and etc. Shift means the direction of change of the concentration of certain species opposing the stress. Examples of reversible systems at equilibrium are the following: 1. Weak acids or bases 2. Saturated solutions of salts 3. -
United States Patent (19) 11 Patent Number: 5,212,098 Hoffmann Et Al
III USOO5212098A United States Patent (19) 11 Patent Number: 5,212,098 Hoffmann et al. (45) Date of Patent: May 18, 1993 54 BROMIDE ION DETERMINATION Determinative of Alkali Metal Bromides and Thiocya 75 Inventors: Andrew F. Hoffmann, Walworth; nates in Mixtures', Anal. Chem. 40(13), Nov. 1968, pp. Richard W. Bauer, Jr., Rochester, 2052-2053. both of N.Y. Kolesnikova, T. A. and R. A. Etinger, "Determination of Bromide and Thiocyanate in Developer Solutions', 73) Assignee: Eastman Kodak Company, Tekh. Kino Telev. 12(2) 33-34, 1968, English Abstract Rochester, N.Y. Only. 21 Appl. No.: 766,944 Chemical Reviews, "Adsorption Indicators', I. M. Kolthoff, vol. 16, 87 (1935). 22 Filed: Sep. 27, 1991 New Methods of Volumetric Analysis, Part VII, "Adsorp tion Indicators for Precipitation Titrations', K. Fajans, Related U.S. Application Data D. Van Norstrand Company, Inc., New York (1938). 63 Continuation-in-part of Ser. No. 761,181, Sep. 17, 1991, abandoned. Primary Examiner-James C. Housel Assistant Examiner-Jan M. Ludlow 51) int. Cl. ............................................. G01N 33/00 Attorney, Agent, or Firm-L. George Legg 52 U.S. C. .................................... 436/125; 436/124; 436/163; 436/175; 436/178; 430/399 57 ABSTRACT 58 Field of Search ............... 436/124, 125, 163, 164, Bromide ion content in a photographic developer is an 436/175, 178; 430/399 important variable to be controlled by photoprocessors 56 References Cited who process color reversal material or color negative film. The bromide content of such developers can be U.S. PATENT DOCUMENTS determined by titration with silver ion, using tetraiodo 3,329,468 7/1967 Rupe .................................. -
Thiocyanate Complexes of Osmium
University of the Pacific Scholarly Commons University of the Pacific Theses and Dissertations Graduate School 1953 Thiocyanate complexes of osmium Craig Albert Townsend Jr. University of the Pacific Follow this and additional works at: https://scholarlycommons.pacific.edu/uop_etds Part of the Chemistry Commons Recommended Citation Townsend, Craig Albert Jr.. (1953). Thiocyanate complexes of osmium. University of the Pacific, Thesis. https://scholarlycommons.pacific.edu/uop_etds/343 This Thesis is brought to you for free and open access by the Graduate School at Scholarly Commons. It has been accepted for inclusion in University of the Pacific Theses and Dissertations by an authorized administrator of Scholarly Commons. For more information, please contact [email protected]. THIOCYANATE COHPLEXES OF OSJYliUJ:vi A Thesis presented to The Faculty of the Department of Chemistry College of the Pacific In Partial Fulfillment pf the Requirements for the Degree }'laster of Arts ,by ,Craig Albert Townsend Jr. "I ,A_ugust 1953 ·ACKN 0\rJLEDGEiviENT The writer is indebted to the members of the staff for completion of this work, especially to Dr. Emerson Cobb for his encouragement and to Dr. Don DeVault for assistance in the mathematical computations involved in the solution of the problem. TABLE OF CON 'l'EN 'l'S PAGE Properties and Uses of Osmium. • • • • • . • • . • 1 Spectrophotometric Methods • • • • • • • • 5 11 Experimental Observations • . 23 Discussion of Results • • • . LIST OF TABLES TABLE PAGE I. Optical Densities of Thiocyanate and Osmium Nixtures before the Attain- ment of Equilibrium • • • • • • • • 16 II. Optical Densities of Thiocyanate and Osmium Mixtures after the Attain- ment of Equilibrium • . 17 III. Values for the Dissociation Constant by the Hethod of Frank and Ostwald •• • • 18 IV. -
Pharmaceuticals and Medical Devices Safety Information No
Pharmaceuticals and Medical Devices Safety Information No. 260 August 2009 Table of Contents 1. Tricyclic and tetracyclic antidepressants, associated with aggression ................................................................................................... 3 2. Important Safety Information .................................................................. 9 .1. Telmisartan ··························································································· 9 .2. Phenytoin, Phenytoin/Phenobarbital, Phenytoin/Phenobarbital/ Caffeine and Sodium Benzoate, Phenytoin Sodium ··························· 13 3. Revision of PRECAUTIONS (No. 208) Lamotrigine (and 9 others) ············································································ 17 4. List of products subject to Early Post-marketing Phase Vigilance ..................................................... 21 This Pharmaceuticals and Medical Devices Safety Information (PMDSI) is issued based on safety information collected by the Ministry of Health, Labour and Welfare. It is intended to facilitate safer use of pharmaceuticals and medical devices by healthcare providers. PMDSI is available on the Pharmaceuticals and Medical Devices Agency website (http://www.pmda.go.jp/english/index.html) and on the MHLW website (http://www.mhlw.go.jp/, Japanese only). Published by Translated by Pharmaceutical and Food Safety Bureau, Pharmaceuticals and Medical Devices Agency Ministry of Health, Labour and Welfare Pharmaceutical and Food Safety Bureau, Office of Safety I, Ministry of -
Bromides Potassium Bromide, Sodium Bromide Kbr and Nabr Are Other Names for This Medication
Bromides Potassium Bromide, Sodium Bromide KBr and NaBr are other names for this medication. How Is This Medication Useful? • Potassium bromide or sodium bromide are used to treat dogs with epilepsy, either alone, or in combination with other drugs. • They are used in cats with epilepsy on if other drugs fail to work well. • Bromides are a chemical rather than an FDA approved drug. American Chemical Society (ACS) grade bromide should be used for seizure therapy. Are There Conditions or Times When Its Use Might Cause More Harm Than Good? • Bromides must be eliminated from the body by the kidneys. Animals with severe kidney disease may have problems with this drug, if they don’t make enough urine. • Human infants have suffered growth retardation when born to mothers who took bromides. Potassium bromide should probably not be used in pregnant or nursing mothers unless the benefit of use outweighs the risk of adverse effects. • The intake of chloride will have to be very carefully controlled while your animal is on this drug. Do not give your animal any salty treats and always check with your veterinarian before giving new foods or snacks while on this medication. • If your animal has any of the above conditions, talk to your veterinarian about the potential risks of using the medication versus the benefits that it might have. • Some cats can develop fluid in the lungs while taking bromides and cats who are taking bromides should do so only when seizures can not be controlled by other drugs, and only if carefully monitored for breathing problems. -
Pharmacology
STATE ESTABLISHMENT «DNIPROPETROVSK MEDICAL ACADEMY OF HEALTH MINISTRY OF UKRAINE» V.I. MAMCHUR, V.I. OPRYSHKO, А.А. NEFEDOV, A.E. LIEVYKH, E.V.KHOMIAK PHARMACOLOGY WORKBOOK FOR PRACTICAL CLASSES FOR FOREIGN STUDENTS STOMATOLOGY DEPARTMENT DNEPROPETROVSK - 2016 2 UDC: 378.180.6:61:615(075.5) Pharmacology. Workbook for practical classes for foreign stomatology students / V.Y. Mamchur, V.I. Opryshko, A.A. Nefedov. - Dnepropetrovsk, 2016. – 186 p. Reviewed by: N.I. Voloshchuk - MD, Professor of Pharmacology "Vinnitsa N.I. Pirogov National Medical University.‖ L.V. Savchenkova – Doctor of Medicine, Professor, Head of the Department of Clinical Pharmacology, State Establishment ―Lugansk state medical university‖ E.A. Podpletnyaya – Doctor of Pharmacy, Professor, Head of the Department of General and Clinical Pharmacy, State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ Approved and recommended for publication by the CMC of State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ (protocol №3 from 25.12.2012). The educational tutorial contains materials for practical classes and final module control on Pharmacology. The tutorial was prepared to improve self-learning of Pharmacology and optimization of practical classes. It contains questions for self-study for practical classes and final module control, prescription tasks, pharmacological terms that students must know in a particular topic, medical forms of main drugs, multiple choice questions (tests) for self- control, basic and additional references. This tutorial is also a student workbook that provides the entire scope of student’s work during Pharmacology course according to the credit-modular system. The tutorial was drawn up in accordance with the working program on Pharmacology approved by CMC of SE ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ on the basis of the standard program on Pharmacology for stomatology students of III - IV levels of accreditation in the specialties Stomatology – 7.110105, Kiev 2011.